Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
mirvetuximab soravtansine
MeSH Supplementary Concept Data 2026
Details
Concepts
MeSH Supplementary
mirvetuximab soravtansine
Unique ID
C000607289
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000607289
Entry Term(s)
Elahere
IMGN-853
IMGN853
mirvetuximab soravtansine-gynx
Registry Numbers
98DE7VN88D
Heading Mapped to
*Maytansine
/
analogs & derivatives
*Immunoconjugates
*Antibodies, Monoclonal, Humanized
Frequency
25
Note
an antineoplastic conjugate of M9346A monoclonal antibody and N2'-deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine that targets folate receptor-alpha
Source
Mol Cancer Ther. 2015 Jul;14(7):1605-13.
Date Introduced
2016/05/05
Last Updated
2026/04/10
Expand All
Collapse All
mirvetuximab soravtansine
Preferred
Concept UI
M000617500
Registry Numbers
98DE7VN88D
Terms
mirvetuximab soravtansine
Preferred Term
Term UI
T000929749
Date
08/07/2017
LexicalTag
NON
ThesaurusID
IMGN853
Narrower
Concept UI
M000634905
Terms
IMGN853
Preferred Term
Term UI
T000900397
Date
05/05/2016
LexicalTag
LAB
ThesaurusID
NLM (2016)
IMGN-853
Term UI
T000965830
Date
08/20/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
mirvetuximab soravtansine-gynx
Related
Concept UI
M000770119
Terms
mirvetuximab soravtansine-gynx
Preferred Term
Term UI
T001152187
Date
03/26/2026
LexicalTag
NON
ThesaurusID
NLM (2026)
Elahere
Related
Concept UI
M000770120
Terms
Elahere
Preferred Term
Term UI
T001152188
Date
03/26/2026
LexicalTag
TRD
ThesaurusID
NLM (2026)
page delivered in 0.004s